Monosacáridos

<p>Benzyl 3-O-benzyl-4,6-O-benzylidene-2-deoxy-2-N-phthalamido-a-D-glucopyranoside is a sugar that is used as a building block for the synthesis of glycosaminoglycans. This sugar can be fluorinated, glycosylated, or methylated and is a synthetically modified oligosaccharide with an average molecular weight of about 880 Da. The monomer unit consists of two glucose residues linked by an α(1→4) glycosidic bond. It has been shown to have antihypertensive properties in vitro and in vivo.</p>

<p>1,2,3,4,6-Penta-O-trimethylsilyl-D-glucopyranose is a high purity product custom synthesized for research purposes. It is a sugar that has been modified by the Click modification and fluorination. 1,2,3,4,6-Penta-O-trimethylsilyl-D-glucopyranose is an oligosaccharide with a complex carbohydrate structure that can be used in glycosylation reactions. This product is a saccharide with a CAS number of 19126-99-9.</p>

<p>A beta glycoside with an alkyne handle suitable to click chemistry</p>

<p>Resource for the synthesis of 2-azido- and 2-deoxy-L-glucoses and 1,2-epoxides</p>

<p>2,3,5-Tri-O-benzoyl-a-D-arabinofuranosyl bromide is a glycosylation reagent that can be used in the synthesis of polysaccharides and oligosaccharides. It is also used to modify sugars with methyl and fluorination reagents. 2,3,5-Tri-O-benzoyl-a-D-arabinofuranosyl bromide has CAS number 434868 9.</p>

<p>Allyl 2-acetamido-2-deoxy-a-D-glucopyranoside is a synthetic oligosaccharide that has the ability to bind to the O antigen of bacterial cells. It is used in vaccines as an adjuvant and has been shown to increase antibody production and provide protection against Shigella, a bacterial infection. This compound also shows chemoenzymatic activity, which allows for regiospecifically catalytic conversion of glycosides. Allyl 2-acetamido-2-deoxy-a-D-glucopyranoside binds to specific microbial enzymes that contain an acceptor site, with its catalytic function being activated by these enzymes.</p>

<p>Low-calorie sweetener; additive in detergents, cosmetics, and pharmaceuticals</p>

<p>2,3,5-Tri-O-benzyl-b-D-ribofuranose is a synthetic monosaccharide that is used in the synthesis of complex carbohydrates such as glycosylation and polysaccharides. One use for this chemical is to modify the sugar moiety with methyl groups, yielding 2,3,5-tri-O-methyl b-D-ribofuranose. This modification helps prevent the sugar from being metabolized by enzymes in the body. The chemical can also be fluorinated to yield 2,3,5-trifluoro b-D-ribofuranose.</p>

<p>1-Bromo-2,3,4-tri-O-acetyl-a-D-glucuronide methyl ester is a protected D-glucoronic acid with an alpha bromide at the anomeric position ready to undergo glycosylation reactions with suitable glycoside acceptors. Pharmaceutically active compounds have been used as acceptors to form β-linked D-glucuronide prodrugs which can be used to modify pharmacokinetics, improve solubility and lower the toxicity of the drug.</p>

<p>Benzocaine N-b-D-glucoside is an adjuvant that is used in pharmaceutical products. It has been shown to increase the stability of drugs and prolong their effects. Benzocaine N-b-D-glucoside also enhances the absorption, distribution, and elimination of drugs. This adjuvant has a number of functionalities including being a carbonyl scavenger and having mottling effects on drug particles. Benzocaine N-b-D-glucoside is often used as a pharmaceutical product adjuvant to stabilize formulations and extend the shelf life of medications.</p>

<p>Methyl alpha-D-mannopyranoside is a methylated sugar used as an inhibitor of lectin-conjugate binding. It is commonly used in protein purification for eluting glycoproteins and other glycoconjugates from affinity chromatography columns of agarose lectin. In addition, Methyl alpha-D-mannopyranoside can be used in the mannosylation of lipid nanoparticles (LNPs) for vaccine or drug delivery which targets Antigen Presenting Cells (APCs) through mannose receptors. Methyl alpha-D-mannopyranoside is also known as Methyl alpha-D-mannoside or alpha-Methyl-D-mannoside.</p>

<p>4-Methoxyphenyl 3-O-benzyl-4,6-O-benzylidene-2-deoxy-2-phthalimido-b-D-glucopyranoside is a complex carbohydrate that has been modified with methylation and glycosylation. It has been synthesized using the following reactants: 4-(methoxy)phenol, benzaldehyde, and 2,3,4,6,-tetraacetylpiperidine. This product has a CAS number of 129575–88–8 and is available for custom synthesis in quantities from 1 gram to 50 kilograms. This product is used as a custom synthesis for oligosaccharides or polysaccharides.</p>

<p>Allyl 2-acetamido-2-deoxy-β-D-glucopyranoside is a modification of the sugar molecule. It is an oligosaccharide composed of a monosaccharide and one or more other saccharides.</p>

<p>Methyl a-D-xylopyranoside is an iron chelator that can be used as a mycobacterial drug candidate. It binds to both ferric and ferrous iron, and has been shown to inhibit the uptake of ferric iron by Mycobacterium tuberculosis. It also inhibits the synthesis of siderophores, which are molecules produced by bacteria in order to acquire iron from their environment. Methyl a-D-xylopyranoside does not bind to the alpha-d-glucopyranoside moiety typically found in iron complexes. This is due to its hydroxamate group, which causes it to have an increased affinity for Fe3+. This compound is active against gram negative bacteria such as E. coli and Salmonella enterica serovar Typhimurium, but not against gram positive organisms such as Staphylococcus aureus or Streptococcus pneumoniae.</p>

<p>L-Lyxono-1,4-lactone is a dehydrogenase that synthesizes hydroxamic acids from aldonic acids. Hydroxamic acids are used as herbicides and insecticides. L-Lyxono-1,4-lactone has been shown to be active against ochrobactrum and branched-chain bacteria. The enzyme catalyzes the cleavage of an aldonic acid to form an alcohol and an alpha,beta unsaturated ketone. This reaction is stereoselective, with the product being the same chiral center in both cases. The enzyme also shows chemometric properties by being able to measure salinity levels in water samples.</p>

<p>2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl amine is an artificial carbohydrate with a fluorinated sugar. It is synthesized by reacting 2,3,4,6-tetra-O-acetyl-b-D-glucopyranosyl chloride with ammonia and methyl iodide. The compound can be used to modify the sugar residues of glycosides or polysaccharides. It has been shown to have high purity and can be used in the synthesis of complex carbohydrates.</p>

<p>Methyl 2,3,4,6-tetra-O-benzyl-b-D-thiogalactopyranoside is a synthetic monosaccharide that has been modified with fluorination and glycosylation. It is a product of the click reaction, which is a chemical modification that involves the formation of an aziridine and an alkene in one step. This product has been used for the synthesis of oligosaccharides and complex carbohydrates.</p>

<p>2-Deoxy-2-fluoro-D-mannose is known for its antiviral properties as a sugar analog and glycosylation inhibitor. It works by inhibiting the glycosylation of viral envelope proteins, which can prevent viral replication and reduce viral infectivity. Studies have shown that 2-deoxy-2-fluoro-D-mannose can inhibit the replication of various viruses, including influenza A virus, human immunodeficiency virus (HIV), and hepatitis C virus (HCV). Inhibition of viral glycosylation by 2-Deoxy-2-fluoro-D-mannose can also enhance the effectiveness of some antiviral drugs, making them more potent.</p>

<p>a-Homonojirimycin is a chaperone that is effective in inhibiting HIV infection. It has been shown to inhibit the activity of chymotrypsin, carboxypeptidase A, and aminopeptidase B. The model system used for this compound was the human liver, which showed that a-homonojirimycin had a potent inhibitory activity against these enzymes. This drug also has a dry weight of 1,520 g/mol and an effective dose of 0.01 mg/mL. In vitro studies have shown that a-homonojirimycin inhibits influenza virus by binding to the hemagglutinin protein on the surface of the virus and preventing its attachment to host cells.</p>

<p>3,4,6-Tri-O-benzyl-D-glucal is a benzyl protected, 2,3 unsaturated glucal used as a chiral intermediate. The C2-C3 double bond of the pyranose ring can be modified via a variety of reactions including: hydrogenation, oxidation, hydroxylation, and aminohydroxylation, to generate structural complexity. 3,4,6-Tri-O-benzyl-D-glucal also minimizes tedious protecting-group strategies required for fully oxygenated sugars. The products of 2,3 unsaturated glycosides as chiral intermediates have played a role in the synthesis of many biologically active compounds, such as, nucleosides and modified sugar derivatives.</p>